[Skip to Content]
[Skip to Content Landing]
April 2002

Endocrinologic Changes in Male Patients With Melanoma During Interferon Alfa-2b Therapy

Author Affiliations

Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002

Arch Dermatol. 2002;138(4):541-542. doi:10.1001/archderm.138.4.533

Chronic and malignant diseases have been shown to affect gonadal hormone secretion.1,2 There are only limited data about endocrinologic changes in male patients with melanoma. Meikle et al3 reported reduced production of testosterone in men with metastatic renal carcinoma or melanoma during therapy with interleukin 2. In contrast, interferon alfa seems to have no effects on the testes of men with hematological diseases or hepatitis C.4

First Page Preview View Large
First page PDF preview
First page PDF preview